Abstract
Tumor invasion is likely driven by the product of intrinsic and extrinsic stresses, reduced intercellular adhesion, and reciprocal interactions between the cancer cells and the extracellular matrix (ECM). The ECM is a dynamic material system that is continuously evolving with the tumor microenvironment. Although it is widely reported that cancer cells degrade the ECM to create paths for migration using membrane-bound and soluble enzymes, other nonenzymatic mechanisms of invasion are less studied and not clearly understood. To explore tumor invasion that is independent of enzymatic degradation, we have created an open three-dimensional (3D) microchannel network using a novel bioconjugated liquid-like solid (LLS) medium to mimic both the tortuosity and the permeability of a loose capillary-like network. The LLS is made from an ensemble of soft granular microgels, which provides an accessible platform to investigate the 3D invasion of glioblastoma (GBM) tumor spheroids using in situ scanning confocal microscopy. The surface conjugation of the LLS microgels with type 1 collagen (COL1-LLS) enables cell adhesion and migration. In this model, invasive fronts of the GBM microtumor protruded into the proximal interstitial space and may have locally reorganized the surrounding COL1-LLS. Characterization of the invasive paths revealed a super-diffusive behavior of these fronts. Numerical simulations suggest that the interstitial space guided tumor invasion by restricting available paths, and this physical restriction is responsible for the super-diffusive behavior. This study also presents evidence that cancer cells utilize anchorage-dependent migration to explore their surroundings, and geometrical cues guide 3D tumor invasion along the accessible paths independent of proteolytic ability.
Original language | English |
---|---|
Article number | 021001 |
Journal | Biointerphases |
Volume | 18 |
Issue number | 2 |
DOIs | |
State | Published - Mar 2023 |
Externally published | Yes |
Funding
Duy T. Nguyen was supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1842473. Elias J. Sayour is supported by NIH (Award Nos. R37 CA251978 and R01 CA266857). Paul Castilo was supported by FDOH Live Like Bella Discovery grant (22L07), UFHCC/CTSI KL2TR001429 and UL1TR001427 and the Stop Children's Cancer foundation (No. F023891). This project was funded under a research agreement from Merck Sharp & Dohme Corp.
Funders | Funder number |
---|---|
FDOH Live Like Bella Discovery grant | 22L07 |
National Science Foundation | DGE-1842473 |
National Institutes of Health | R37 CA251978, R01 CA266857 |
Children's Cancer Foundation | F023891 |
Indiana Clinical and Translational Sciences Institute | KL2TR001429, UL1TR001427 |
Merck Sharp and Dohme | |
Cancer Center, University of Florida Health |